Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

1.6K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
1.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

619
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
619
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

498
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
498
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

321
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
321
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

565
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
565

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primates.

Science advances·2025
Same author

Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort.

NPJ Parkinson's disease·2025
Same author

Endorsement of: "Position paper for the treatment of nightmare disorder in adults: An American Academy of Sleep Medicine position paper" by the World Sleep Society.

Sleep medicine·2025
Same author

Upper and Lower Gastrointestinal Symptom Association and Duration Preceding Parkinson's Disease.

Gastro hep advances·2024
Same author

Correction to: Role of sleep in neurodegeneration: the consensus report of the 5th Think Tank World Sleep Forum.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2024
Same author

Role of sleep in neurodegeneration: the consensus report of the 5th Think Tank World Sleep Forum.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2023

Related Experiment Video

Updated: Jan 30, 2026

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

32.4K

Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.

L M Chahine1, A Iranzo2, A Fernández-Arcos2

  • 11Department of Neurology, The University of Pittsburgh, Pittsburgh, PA USA.

NPJ Parkinson'S Disease
|February 1, 2019
PubMed
Summary
This summary is machine-generated.

REM sleep behavior disorder (RBD) is linked to Parkinson's disease. Basic clinical factors do not predict dopamine transporter (DAT) deficits in RBD patients, highlighting the need for biomarker assessment.

More Related Videos

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
08:08

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy

Published on: October 16, 2013

11.0K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.4K

Related Experiment Videos

Last Updated: Jan 30, 2026

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

32.4K
Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
08:08

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy

Published on: October 16, 2013

11.0K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

12.4K

Area of Science:

  • Neurology
  • Neuroscience
  • Sleep Medicine

Background:

  • REM sleep behavior disorder (RBD) is a significant predictor of future α-synucleinopathies, including Parkinson's Disease.
  • Dopamine transporter (DAT) binding deficits in individuals with RBD indicate a higher risk of neurodegenerative disease conversion.
  • Identifying clinical predictors of DAT deficits in RBD is crucial for risk stratification.

Purpose of the Study:

  • To investigate if basic clinical features can predict Dopamine Transporter (DAT) deficits in individuals with REM sleep behavior disorder (RBD).

Main Methods:

  • Analysis of participants from the Parkinson Progression Markers Initiative (PPMI) RBD cohort.
  • Utilized DAT SPECT imaging, physical examinations, cognitive screening, and non-motor symptom questionnaires.
  • Compared individuals with and without DAT binding deficits.

Main Results:

  • No significant demographic or clinical differences were found between the DAT deficit group (n=49) and the normal DAT binding group (n=26).
  • This suggests that basic clinical assessments are insufficient to predict DAT binding abnormalities in RBD.
  • The findings underscore the importance of objective biomarkers.

Conclusions:

  • Clinical predictors alone are inadequate for identifying individuals with RBD who have abnormal DAT binding.
  • Objective biomarker assessments, such as DAT SPECT imaging, are essential when recruiting RBD cohorts at high risk for neurodegenerative disorders.